Molecular Imaging 2017
SPECTRO GLIO Newly Diagnosed Glioblastoma Prospective multicentric phase III trial- Coordination Anne Laprie Promoted by Institut Claudius Regaud– financed by French national cancer institute
220 patients – 9 institutions
MRI T1, Flair, diff, Perf + spectro
Randomization
60 Gy + TMZ + 72 Gy/2,4 Gy IMRT SIB guided by MR spectroscopy
60 Gy + TMZ
MRI T1, Flair, diff, Perf + spectro /2months
Global survival
11
Made with FlippingBook - Online magazine maker